Information  X 
Enter a valid email address

Immupharma PLC (IMM)

  Print      Mail a friend       Annual reports

Thursday 28 June, 2018

Immupharma PLC

Result of AGM

RNS Number : 8788S
Immupharma PLC
28 June 2018




                                                                                                                       28 JUNE 2018


This announcement contains inside information for the purposes of Article 7 of Regulation (EU) 596/2014.






ImmuPharma PLC (LSE:IMM), ("ImmuPharma" or the "Company"), the specialist drug discovery and development company, held its AGM earlier today and is pleased to announce that all resolutions were duly passed.




For further information please contact:


ImmuPharma PLC (

+ 44 (0) 20 7152 4080

Tim McCarthy, Chairman


Lisa Baderoon, Head of Investor Relations

Twitter: @immupharma


+ 44 (0) 7721 413496





Northland Capital Partners Limited (NOMAD & Joint Broker)

David Hignell, Dugald Carlean, Jamie Spotswood, Corporate Finance

Rob Rees, Corporate Broking



+44 (0)20 3861 6625





Bryan, Garnier & Co. (Joint Broker)

Phil Walker, Corporate Finance

Dominic Wilson, Sales

+44 (0)20 7332 2500










This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit

a d v e r t i s e m e n t